Debt-to-equity of HTG MOLECULAR DIAGNOSTICS, INC from 30 Sep 2015 to 31 Mar 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: HTG MOLECULAR DIAGNOSTICS, INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 31 Mar 2023.
HTG MOLECULAR DIAGNOSTICS, INC Debt-to-equity for the quarter ending 31 Mar 2023 was 410%, a 197% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q1 2023	410%	+272%	+197%	31 Mar 2023
Q4 2022	250%	+121%	+93%	31 Dec 2022
Q3 2022	233%	+111%	+91%	30 Sep 2022
Q2 2022	175%	+53%	+44%	30 Jun 2022
Q1 2022	138%	+14%	+12%	31 Mar 2022
Q4 2021	129%	+15%	+13%	31 Dec 2021
Q3 2021	122%	+20%	+20%	30 Sep 2021
Q2 2021	121%	+30%	+33%	30 Jun 2021
Q1 2021	123%	+21%	+21%	31 Mar 2021
Q4 2020	115%	+4.8%	+4.4%	31 Dec 2020
Q3 2020	102%	-14%	-12%	30 Sep 2020
Q2 2020	91%	-33%	-26%	30 Jun 2020
Q1 2020	102%	+2.2%	+2.2%	31 Mar 2020
Q4 2019	110%	+23%	+26%	31 Dec 2019
Q3 2019	116%	-0.16%	-0.14%	30 Sep 2019
Q2 2019	124%	-55%	-31%	30 Jun 2019
Q1 2019	100%	-310%	-76%	31 Mar 2019
Q4 2018	87%	+533%		31 Dec 2018
Q3 2018	116%	+511%		30 Sep 2018
Q2 2018	178%	+636%		30 Jun 2018
Q1 2018	410%	+1084%		31 Mar 2018
Q4 2017	-446%	-2015%	-128%	31 Dec 2017
Q3 2017	-395%	-753%	-210%	30 Sep 2017
Q2 2017	-458%	-646%	-343%	30 Jun 2017
Q1 2017	-674%	-798%	-646%	31 Mar 2017
Q4 2016	1569%	+2751%		31 Dec 2016
Q3 2016	358%	+455%		30 Sep 2016
Q2 2016	188%			30 Jun 2016
Q1 2016	124%			31 Mar 2016
Q4 2015	-1182%			31 Dec 2015
Q3 2015	-97%			30 Sep 2015

* An asterisk sign (*) next to the value indicates that the value is likely invalid.